<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3490">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382508</url>
  </required_header>
  <id_info>
    <org_study_id>RHM CHI1061</org_study_id>
    <nct_id>NCT04382508</nct_id>
  </id_info>
  <brief_title>Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.</brief_title>
  <acronym>ImmunoCOVID</acronym>
  <official_title>Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Southampton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alder Hey Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Birmingham Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bradford Royal Infirmary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bristol Royal Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cardiff and Vale University Health Board</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Great North Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Great Ormond Street Hospital for Children NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oxford University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leeds Teaching Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norfolk and Norwich University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nottingham Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Alexandra Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Hospital for Sick Children, Glasgow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Manchester Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Marsden NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northern Care Alliance NHS Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Sussex County Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sheffield Children's NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St George's University Hospital National Health Service Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swansae Bay University Health Board</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals Coventry and Warwickshire National Health Service Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>East Lancashire Hospitals National Health Service Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Imperial College Healthcare National Health Service Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heatlh Service Ayrshire and Arran</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Southampton NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A weekly questionnaire is sent to patients and parents of patients who are vulnerable for
      infections. Possible symptoms of COVID19 are asked for and use of healthcare services and
      testing for COVID19. Weekly reports are being send to the national institutions to update
      advice given to this group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to allow immunosuppressed children, their parents or adult patients to
      self-record their experiences of COVID-19 and other viral respiratory illnesses. Patients,
      parents and of immunosuppressed patients and patients aged 16-17 yrs will be provided with
      online information and asked to fill in online questionnaires at baseline and weekly
      thereafter. Information collected includes medication, symptoms, contact with health care
      providers, test results and impact on daily activities. Data will be collected and analysed
      weekly to be able to monitor any potential risk factors for severe disease. This study is
      complementary to, and not overlapping with, the global ISARIC World Health Organisation
      protocol that will be studying COVID-19 cases admitted to all National Health Service (NHS)
      Trusts, including all children.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 22, 2020</start_date>
  <completion_date type="Anticipated">March 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 21, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To describe COVID19 infection in children/adults who are vulnerable for infection in an outpatients setting</measure>
    <time_frame>1 year</time_frame>
    <description>To describe frequency of cough, fever, diarrhoea, shortness of breath, sore throat, blocked nose, red eyes, headache, joint pain, muscle pain, fatigue, chills, nausea, vomiting, diarrhoea over a year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of children/adults tested positive for COVID19</measure>
    <time_frame>1 year</time_frame>
    <description>Patient/parent reported positive tests for COVID19</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of children/adults admitted in hospital because of COVID19</measure>
    <time_frame>1 year</time_frame>
    <description>Patient/parent reported admissions in hospital because of COVID19</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the impact of COVID19 infection on the daily activities of immunosuppressed adults and children</measure>
    <time_frame>1 year</time_frame>
    <description>Patient/parent reported effect of COVID19 on daily activities</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Immune Suppression</condition>
  <condition>Immune Deficiency</condition>
  <condition>Infection</condition>
  <condition>COVID</condition>
  <condition>Children, Adult</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>A weekly questionnaire will be filled in</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children and adults vulnerable for infection due to a condition or to medication they are
        using.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children part: Parent of immunosuppressed patient aged &lt;16 years or immunosuppressed
             patient aged 16-17 years

          -  Adult part: Immunosuppressed patient aged &gt;17 years

          -  Family or themselves able to complete the questionnaire which will be in English (due
             to current resources available translation will not be possible)

          -  Reliable access to the internet

        Exclusion Criteria:

          -  Unable to understand English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Hans de Graaf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Southampton NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Southampton NHS FT</name>
      <address>
        <city>Southampton</city>
        <state>Hampshire</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.uhs.nhs.uk/ClinicalResearchinSouthampton/Public-and-patients/Featured-research-studies/Featured-research-ImmunoCOVID19-study.aspx</url>
    <description>Study website</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

